Next Article in Journal
Psychrophily and Catalysis
Next Article in Special Issue
Adhesion of Diarrheagenic Escherichia coli and Inhibition by Glycocompounds Engaged in the Mucosal Innate Immunity
Previous Article in Journal
Endolithic Microbial Life in Extreme Cold Climate: Snow Is Required, but Perhaps Less Is More
Biology 2013, 2(2), 702-718; doi:10.3390/biology2020702

Use of Tetravalent Galabiose for Inhibition of Streptococcus Suis Serotype 2 Infection in a Mouse Model

1,* , 2
1 Department of Medicinal Chemistry and Chemical Biology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands 2 Department of Microbiology and Infection Control (MI), Statens Serum Institut, Copenhagen, Denmark 3 Department of Biosciences, Division of Biochemistry and Biotechnology, University of Helsinki, P.O.B. 56, Helsinki FI-00014, Finland 4 Department of Medical Biochemistry and Genetics, University of Turku, Kiinamyllynkatu 10, Turku FI-20520, Finland
* Author to whom correspondence should be addressed.
Received: 14 March 2013 / Revised: 26 March 2013 / Accepted: 28 March 2013 / Published: 8 April 2013
(This article belongs to the Special Issue Bacterial Adhesion)
View Full-Text   |   Download PDF [851 KB, 15 April 2013; original version 8 April 2013]   |   Browse Figures


Streptococcus suis is an important swine pathogen associated with a variety of infections such as meningitis, arthritis and septicemia. The bacterium is zoonotic and has been found to cause meningitis especially in humans occupationally exposed to infected pigs. Since adhesion is a prerequisite for colonization and subsequent infection, anti-adhesion treatment seems a natural alternative to traditional treatment with antibiotics. In order to optimize the inhibitory potency a multivalency approach was taken in the inhibitor design. A synthetic tetravalent galabiose compound was chosen which had previously shown promising anti-adhesion effects with S. suis in vitro. The aim of this study was to evaluate the in vivo effects of the compound using an infection peritonitis mouse model. As such S. suis serotype 2 infection and treatment were tested in vivo and the effects were compared to the effect of treatment with penicillin.
Keywords: tetravalent galabiose; Streptococcus suis; adhesion inhibition; mouse model tetravalent galabiose; Streptococcus suis; adhesion inhibition; mouse model
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Pieters, R.J.; Slotved, H.-C.; Mortensen, H.M.; Arler, L.; Finne, J.; Haataja, S.; Joosten, J.A.F.; Branderhorst, H.M.; Krogfelt, K.A. Use of Tetravalent Galabiose for Inhibition of Streptococcus Suis Serotype 2 Infection in a Mouse Model. Biology 2013, 2, 702-718.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Biology EISSN 2079-7737 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert